Basit öğe kaydını göster

MITOCHONDRIA-LYTIC ACTION OF WARFARIN IN LYMPHOCYTES

dc.contributor.authorARDA, O
dc.contributor.authorDERMAN, U
dc.contributor.authorTASYUREKLI, M
dc.contributor.authorBERKARDA, B
dc.date.accessioned2021-03-02T21:54:42Z
dc.date.available2021-03-02T21:54:42Z
dc.date.issued1992
dc.identifier.citationBERKARDA B., ARDA O., TASYUREKLI M., DERMAN U., "MITOCHONDRIA-LYTIC ACTION OF WARFARIN IN LYMPHOCYTES", INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, cilt.30, sa.8, ss.277-279, 1992
dc.identifier.issn0946-1965
dc.identifier.otherav_099a8c7e-09e9-4302-82bf-f48cc42cf908
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/12263
dc.description.abstractWarfarin given as a single dose of 20 mg induces lysis of mitochondria in lymphocytes from chronic and acute lymphocytic leukemias studied under the electron microscope. Normal lymphocytes remain unchanged. This cytotoxic actin may be due to superoxide radicals produced in the malignant cells by warfarin, which is a potent electron-transferring substance.
dc.language.isoeng
dc.subjectEczacılık
dc.subjectTemel Eczacılık Bilimleri
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectSağlık Bilimleri
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.titleMITOCHONDRIA-LYTIC ACTION OF WARFARIN IN LYMPHOCYTES
dc.typeMakale
dc.relation.journalINTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
dc.contributor.department, ,
dc.identifier.volume30
dc.identifier.issue8
dc.identifier.startpage277
dc.identifier.endpage279
dc.contributor.firstauthorID113692


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster